Molecular Therapy: Oncology最新文献

筛选
英文 中文
Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma 开发治疗胰腺导管腺癌的吉西他滨修饰miRNA模拟物
Molecular Therapy: Oncology Pub Date : 2024-01-01 DOI: 10.1016/j.omton.2024.200769
John G. Yuen, Ga-Ram Hwang, A. Fesler, Erick Intriago, Amartya Pal, Anushka Ojha, Jingfang Ju
{"title":"Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma","authors":"John G. Yuen, Ga-Ram Hwang, A. Fesler, Erick Intriago, Amartya Pal, Anushka Ojha, Jingfang Ju","doi":"10.1016/j.omton.2024.200769","DOIUrl":"https://doi.org/10.1016/j.omton.2024.200769","url":null,"abstract":"","PeriodicalId":516670,"journal":{"name":"Molecular Therapy: Oncology","volume":"93 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139640840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs TROP2 在三阴性乳腺癌 CTC 中高度表达,是上皮间质 CTC 的潜在标记物
Molecular Therapy: Oncology Pub Date : 2024-01-01 DOI: 10.1016/j.omton.2024.200762
Qingyu Liao, Ruiming Zhang, Zuli Ou, Yan Ye, Qian Zeng, Yange Wang, Anqi Wang, Tingmei Chen, Chengsen Chai, Bianqin Guo
{"title":"TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs","authors":"Qingyu Liao, Ruiming Zhang, Zuli Ou, Yan Ye, Qian Zeng, Yange Wang, Anqi Wang, Tingmei Chen, Chengsen Chai, Bianqin Guo","doi":"10.1016/j.omton.2024.200762","DOIUrl":"https://doi.org/10.1016/j.omton.2024.200762","url":null,"abstract":"","PeriodicalId":516670,"journal":{"name":"Molecular Therapy: Oncology","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139640731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors. 用于靶向治疗表皮生长因子受体携带肿瘤的单纯疱疹病毒。
Molecular Therapy: Oncology Pub Date : 2024-01-01 DOI: 10.1016/j.omton.2024.200761
S. Ingusci, Bonnie L. Hall, Justus B. Cohen, J. Glorioso
{"title":"Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors.","authors":"S. Ingusci, Bonnie L. Hall, Justus B. Cohen, J. Glorioso","doi":"10.1016/j.omton.2024.200761","DOIUrl":"https://doi.org/10.1016/j.omton.2024.200761","url":null,"abstract":"","PeriodicalId":516670,"journal":{"name":"Molecular Therapy: Oncology","volume":"101 5-6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140516991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing anti-tumor immunity 靶向 MELK 可通过增强抗肿瘤免疫力提高 PD-1 在宫颈癌中的阻断效率
Molecular Therapy: Oncology Pub Date : 2024-01-01 DOI: 10.1016/j.omton.2024.200759
Dongjiao Wang, Fei Zou, Yu Li, Jinqiu Hu, Ling Gao
{"title":"Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing anti-tumor immunity","authors":"Dongjiao Wang, Fei Zou, Yu Li, Jinqiu Hu, Ling Gao","doi":"10.1016/j.omton.2024.200759","DOIUrl":"https://doi.org/10.1016/j.omton.2024.200759","url":null,"abstract":"","PeriodicalId":516670,"journal":{"name":"Molecular Therapy: Oncology","volume":"24 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140524645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信